NEPC typically emerges late during treatment of CRPC, characterized by small cell morphology, down-regulated AR expression, and up-regulated NE markers [10,45,73], unlike the AR pathway dependence of trend-sensitive PCa or AR mutations or overexpression in CRPC. This evidence concerns the gene AR and posterior cortical atrophy.